News
Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...
Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...
Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...
It is part of a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure.
Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...
Swiss pharmaceutical giant Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities, ...
A Swiss drug giant has gotten the message from President Trump’s tariff threats. Novartis said Thursday it will spend $23 ...
On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...
1d
Pharmaceutical Technology on MSNNovartis commits $23bn to US manufacturing amid tariff threatsFollowing the firm’s $1.75bn acquisition of radiopharmaceuticals company Mariana Oncology and the $745m deal with Ratio ...
Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.
Swiss drugmaker Novartis plans a $23 billion investment in building and expanding 10 manufacturing and research facilities in ...
Novartis (NVS, Financials) is investing $23 billion over the next five years to expand its manufacturing and research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results